BeStock  
Stocks › Biotechnology › BCAX

Bicara Therapeutics BCAX

US equityMarket cap rank #3530Biotechnology
$8.44 −$0.68 (-7.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.44 0.00%
Open$8.83
Prev close$9.12
Day range$8.43 – $9.14
Volume814.5K
Market cap$560.31M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$31.63+274.8% vs. price
  • Buy 88%
  • Sell 13%
Low $8.00Now $8.44Avg $31.63High $43.00

Recent rating changes

The last 20 actions on file set price targets from $8.00 to $45.00, averaging $34.75.

DateFirmRatingTarget
11 Nov 2026 H.C. Wainwright BUY $36.00
10 Nov 2026 Morgan Stanley BUY $30.00
10 Nov 2026 Stifel BUY $43.00
10 Nov 2026 BMO Capital BUY $35.00
9 Nov 2026 JonesTrading BUY $30.00
9 Nov 2026 BTIG BUY $37.00
9 Nov 2026 BofA Securities BUY $34.00
4 Nov 2026 BMO Capital BUY $35.00
29 Oct 2026 Stifel BUY $45.00
29 Oct 2026 Goldman Sachs SELL $8.00
27 Oct 2026 BofA Securities BUY $34.00
26 Oct 2026 BTIG BUY $39.00
26 Oct 2026 Stifel BUY $45.00
25 Oct 2026 JonesTrading BUY $30.00
20 Oct 2026 Morgan Stanley BUY $41.00
19 Oct 2026 BofA Securities BUY $34.00
18 Oct 2026 BTIG BUY $39.00
7 Oct 2026 BMO Capital BUY $35.00
8 Sep 2026 JonesTrading BUY $30.00
18 Aug 2026 BMO Capital BUY $35.00

Discussion

No comments yet — be the first to weigh in on BCAX.

Sign in to join the discussion.

Scroll to Top